BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22122125)

  • 1. Biomarkers in sickle cell disease.
    Rees DC; Gibson JS
    Br J Haematol; 2012 Feb; 156(4):433-45. PubMed ID: 22122125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease.
    Chirico EN; Faës C; Connes P; Canet-Soulas E; Martin C; Pialoux V
    Sports Med; 2016 May; 46(5):629-39. PubMed ID: 26666745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment.
    Piccin A; Murphy C; Eakins E; Rondinelli MB; Daves M; Vecchiato C; Wolf D; Mc Mahon C; Smith OP
    Eur J Haematol; 2019 Apr; 102(4):319-330. PubMed ID: 30664257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.
    Shilo NR; Morris CR
    Expert Rev Hematol; 2017 Oct; 10(10):875-890. PubMed ID: 28817980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.
    Hamali HA
    Hemoglobin; 2023 Nov; 47(6):205-214. PubMed ID: 38189099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological insights in sickle cell disease.
    Odièvre MH; Verger E; Silva-Pinto AC; Elion J
    Indian J Med Res; 2011 Oct; 134(4):532-7. PubMed ID: 22089617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular pathophysiology of sickle cell disease.
    Connes P; Renoux C; Joly P; Nader E
    Presse Med; 2023 Dec; 52(4):104202. PubMed ID: 37944640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of Sickle Cell Disease.
    Sundd P; Gladwin MT; Novelli EM
    Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
    Gbotosho OT; Kapetanaki MG; Kato GJ
    Front Immunol; 2020; 11():561917. PubMed ID: 33584641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in sickle cell disease: an overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies.
    Silva DGH; Belini Junior E; de Almeida EA; Bonini-Domingos CR
    Free Radic Biol Med; 2013 Dec; 65():1101-1109. PubMed ID: 24002011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombosis and sickle cell disease.
    De Franceschi L; Cappellini MD; Olivieri O
    Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease, vasculopathy, and therapeutics.
    Kassim AA; DeBaun MR
    Annu Rev Med; 2013; 64():451-66. PubMed ID: 23190149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease.
    Barodka VM; Nagababu E; Mohanty JG; Nyhan D; Berkowitz DE; Rifkind JM; Strouse JJ
    Blood Cells Mol Dis; 2014 Apr; 52(4):230-5. PubMed ID: 24246527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC; Granger DN
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oxidative stress in the pathogenesis of sickle cell disease.
    Chirico EN; Pialoux V
    IUBMB Life; 2012 Jan; 64(1):72-80. PubMed ID: 22131167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing treatment for sickle cell disease.
    Steinberg MH; Brugnara C
    Expert Opin Investig Drugs; 2002 May; 11(5):645-59. PubMed ID: 11996646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell disease; a general overview.
    Schnog JB; Duits AJ; Muskiet FA; ten Cate H; Rojer RA; Brandjes DP
    Neth J Med; 2004 Nov; 62(10):364-74. PubMed ID: 15683091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced acute lung injury in murine models of sickle cell disease.
    Pritchard KA; Ou J; Ou Z; Shi Y; Franciosi JP; Signorino P; Kaul S; Ackland-Berglund C; Witte K; Holzhauer S; Mohandas N; Guice KS; Oldham KT; Hillery CA
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L705-14. PubMed ID: 12972407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.